Exagen Inc. - Common Stock (NQ:XGN)

8.510 UNCHANGED

Delayed Quote Updated: 4:00 PM EST, Nov 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exagen Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023

April 24, 2023

From Exagen Inc.

Via GlobeNewswire

BTIG Maintains Buy Rating for Exagen: Here's What You Need To Know ↗

March 22, 2023

Via Benzinga

Exagen Earnings Perspective: Return On Capital Employed ↗

March 21, 2023

Via Benzinga

Nike, Tencent Music Entertainment And 3 Stocks To Watch Heading Into Tuesday ↗

March 21, 2023

With US futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results

March 20, 2023

Record AVISE® CTD Volume in 2022

From Exagen Inc.

Via GlobeNewswire

Exagen Earnings Preview ↗

March 17, 2023

Via Benzinga

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023

March 06, 2023

From Exagen Inc.

Via GlobeNewswire

Exagen Inc. to Participate in Upcoming March Conferences

February 27, 2023

From Exagen Inc.

Via GlobeNewswire

Coya Therapeutics' Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments ↗

February 15, 2023

Houston, Texas-based Coya Therapeutics Inc. (NASDAQ: COYA) has just taken a giant leap in making effective proprietary treatments focused on certain neurodegenerative and autoimmune diseases available...

Via Benzinga

Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

January 30, 2023

From Exagen Inc.

Via GlobeNewswire

Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors

January 23, 2023

From Exagen Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 28, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 25, 2022

Via Benzinga

Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket ↗

November 25, 2022

Gainers VEON Ltd. (NASDAQ: VEON) shares rose 31.1% to $0.6095 in pre-market trading after the company agreed to sell its Russian business, Vimpelcom for 130 billion roubles ($2.2 billion).

Via Benzinga

Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday ↗

November 28, 2022

Gainers AEye, Inc. (NASDAQ: LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 24, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 24, 2022

Via Benzinga

Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday ↗

November 25, 2022

Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share.

Via Benzinga

Peering Into Exagen's Recent Short Interest ↗

November 17, 2022

Exagen's (NASDAQ:XGN) short percent of float has fallen 34.48% since its last report. The company recently reported that it has 20 thousand shares sold short, which is 0.19% of all regular shares that...

Via Benzinga

Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday ↗

November 17, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session ↗

November 16, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 16, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 15, 2022

Via Benzinga

Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday ↗

November 16, 2022

Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday.

Via Benzinga

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session ↗

November 15, 2022

Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.

Via Benzinga

Pinterest To $23? Plus This Analyst Slashes PT On Neoleukin Therapeutics By More Than 90% ↗

November 15, 2022

Rosenblatt raised the price target on Pinterest, Inc. (NYSE: PINS) from $21 to $23. Rosenblatt analyst Barton Crockett maintained a Neutral rating on the stock. Pinterest shares rose 2% to $24.91 in...

Via Benzinga

Exagen Inc. Reports Third Quarter 2022 Results

November 14, 2022

Medicare Reimbursement Returns

From Exagen Inc.

Via GlobeNewswire

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

November 08, 2022

From Exagen Inc.

Via GlobeNewswire

Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022

October 31, 2022

From Exagen Inc.

Via GlobeNewswire

Earnings Scheduled For November 14, 2022 ↗

November 14, 2022

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.